Davis R M Inc. lifted its stake in Clorox Co (NYSE:CLX) by 3.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,703 shares of the company’s stock after buying an additional 231 shares during the period. Davis R M Inc.’s holdings in Clorox were worth $1,076,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. JPMorgan Chase & Co. raised its stake in shares of Clorox by 5.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,019,248 shares of the company’s stock worth $153,305,000 after buying an additional 50,360 shares during the period. Man Group plc raised its stake in shares of Clorox by 123.9% during the 3rd quarter. Man Group plc now owns 14,578 shares of the company’s stock worth $2,193,000 after buying an additional 8,066 shares during the period. Mackenzie Financial Corp raised its stake in shares of Clorox by 69.0% during the 3rd quarter. Mackenzie Financial Corp now owns 7,421 shares of the company’s stock worth $1,116,000 after buying an additional 3,031 shares during the period. Kentucky Retirement Systems acquired a new position in shares of Clorox during the 3rd quarter worth approximately $988,000. Finally, B. Riley Wealth Management Inc. acquired a new position in shares of Clorox during the 3rd quarter worth approximately $238,000. Institutional investors and hedge funds own 77.91% of the company’s stock.
Shares of CLX traded up $2.42 during trading hours on Wednesday, hitting $150.60. 1,050,059 shares of the stock were exchanged, compared to its average volume of 1,046,028. The company has a debt-to-equity ratio of 2.93, a quick ratio of 0.66 and a current ratio of 1.10. The stock has a market capitalization of $18.73 billion, a price-to-earnings ratio of 24.06, a PEG ratio of 4.28 and a beta of 0.31. Clorox Co has a 12-month low of $118.92 and a 12-month high of $167.70.
Clorox (NYSE:CLX) last issued its earnings results on Wednesday, May 1st. The company reported $1.44 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.47 by ($0.03). The company had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.37 earnings per share. On average, analysts predict that Clorox Co will post 6.29 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st will be issued a $1.06 dividend. This is a boost from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 annualized dividend and a yield of 2.82%. The ex-dividend date of this dividend is Tuesday, July 30th. Clorox’s dividend payout ratio is presently 61.34%.
Several brokerages have recently weighed in on CLX. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating in a research note on Wednesday, April 24th. BMO Capital Markets set a $168.00 target price on Clorox and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Citigroup dropped their price target on Clorox from $171.00 to $160.00 and set a “neutral” rating for the company in a research report on Thursday, May 2nd. Argus cut Clorox from a “buy” rating to a “hold” rating in a research report on Monday. Finally, Deutsche Bank upgraded Clorox from a “sell” rating to a “hold” rating and set a $139.00 price target for the company in a research report on Thursday, May 2nd. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Clorox has a consensus rating of “Hold” and a consensus target price of $149.57.
In other Clorox news, SVP Andrew J. Mowery sold 5,340 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.40% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This story was published by Sundance Herald and is the sole property of of Sundance Herald. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://sundanceherald.com/2019/05/22/davis-r-m-inc-raises-position-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.